Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 576

2.

IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.

Saha S, Mondal S, Ravindran R, Bhowmick S, Modak D, Mallick S, Rahman M, Kar S, Goswami R, Guha SK, Pramanik N, Saha B, Ali N.

J Immunol. 2007 Oct 15;179(8):5592-603.

PMID:
17911647
[PubMed - indexed for MEDLINE]
Free Article
3.

Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.

Narayan S, Bimal S, Singh SK, Gupta AK, Singh VP, Sinha PK, Das P.

Exp Parasitol. 2009 Jan;121(1):69-75. doi: 10.1016/j.exppara.2008.09.015. Epub 2008 Oct 7.

PMID:
18948098
[PubMed - indexed for MEDLINE]
4.

Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulations.

Banduwardene R, Mullen AB, Carter KC.

Int J Immunopharmacol. 1997 Apr;19(4):195-203.

PMID:
9373770
[PubMed - indexed for MEDLINE]
5.

Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy.

Anam K, Afrin F, Banerjee D, Pramanik N, Guha SK, Goswami RP, Saha SK, Ali N.

Infect Immun. 1999 Dec;67(12):6663-9.

PMID:
10569788
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral Leishmania donovani infection.

Murray HW, Hariprashad J, McDermott DF, Stoeckle MY.

Infect Immun. 1996 Jan;64(1):161-6.

PMID:
8557335
[PubMed - indexed for MEDLINE]
Free PMC Article
7.
8.

Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.

Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK.

Natl Med J India. 2005 May-Jun;18(3):131-3.

PMID:
16130613
[PubMed - indexed for MEDLINE]
9.

Cystatin C as a marker of immune complex-associated renal impairment in a Sudanese population with visceral leishmaniasis.

ElShafie AI, Elghazali G, Rönnelid J, Venge P.

Am J Trop Med Hyg. 2006 Nov;75(5):864-8.

PMID:
17123978
[PubMed - indexed for MEDLINE]
Free Article
10.

Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.

Ritmeijer K, Veeken H, Melaku Y, Leal G, Amsalu R, Seaman J, Davidson RN.

Trans R Soc Trop Med Hyg. 2001 Nov-Dec;95(6):668-72.

PMID:
11816442
[PubMed - indexed for MEDLINE]
11.

Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis.

Alexander J, Carter KC, Al-Fasi N, Satoskar A, Brombacher F.

Eur J Immunol. 2000 Oct;30(10):2935-43.

PMID:
11069076
[PubMed - indexed for MEDLINE]
12.

A time-course study of circulating antigen and parasite-specific antibody in cotton rats infected with Leishmania donovani.

Azazy AA, Chance ML, Devaney E.

Ann Trop Med Parasitol. 1997 Mar;91(2):153-62.

PMID:
9307657
[PubMed - indexed for MEDLINE]
13.

Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis.

Almeida R, D'Oliveira A Jr, Machado P, Bacellar O, Ko AI, de Jesus AR, Mobashery N, Brito Santos J, Carvalho EM.

J Infect Dis. 1999 Nov;180(5):1735-7.

PMID:
10515844
[PubMed - indexed for MEDLINE]
Free Article
14.

Serum interleukin-1 and granulocyte-macrophage colony-stimulating factor levels in protein malnourished patients during acute infection.

Aslan Y, Erduran E, Gedik Y, Mocan H, Okten A, Orem A.

Cent Afr J Med. 1996 Jun;42(6):179-84.

PMID:
8870317
[PubMed - indexed for MEDLINE]
15.

Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

Ghalib HW, Piuvezam MR, Skeiky YA, Siddig M, Hashim FA, el-Hassan AM, Russo DM, Reed SG.

J Clin Invest. 1993 Jul;92(1):324-9.

PMID:
8326000
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India.

Thakur CP, Dedet JP, Narain S, Pratlong F.

Trans R Soc Trop Med Hyg. 2001 Mar-Apr;95(2):187-9.

PMID:
11355558
[PubMed - indexed for MEDLINE]
18.

Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis.

Badaró R, Nascimento C, Carvalho JS, Badaró F, Russo D, Ho JL, Reed SG, Johnson WD Jr, Jones TC.

Eur J Clin Microbiol Infect Dis. 1994;13 Suppl 2:S23-8.

PMID:
7875148
[PubMed - indexed for MEDLINE]
19.

Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.

Mullen AB, Lawrence CE, McFarlane E, Wei XQ, Carter KC.

Immunology. 2006 Nov;119(3):348-54. Epub 2006 Jul 26.

PMID:
16879623
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro.

Kylanpaa ML, Mentula P, Kemppainen E, Puolakkainen P, Aittomaki S, Silvennoinen O, Haapiainen R, Repo H.

Pancreas. 2005 Jul;31(1):23-7.

PMID:
15968243
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk